Cargando…

Rhinitis and Sinusitis

Detalles Bibliográficos
Autor principal:	Scadding, Glenis K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173501/ http://dx.doi.org/10.1016/B978-032304825-5.10032-7

Ejemplares similares

Rhinitis, sinusitis and ocular disease – 2091. The MSYPQ: repeatability and applicability to rhinitis/rhinosinusitis
por: Sami, Amtul Salam, et al.
Publicado: (2013)

Optimal management of allergic rhinitis
por: Scadding, Glenis K
Publicado: (2015)

Upper Airway Disease: Rhinitis and Rhinosinusitis
por: Scadding, Glenis K., et al.
Publicado: (2012)

Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated
por: Kariyawasam, Harsha H, et al.
Publicado: (2010)

EUFOREA Comment on a Misleading Allergic Rhinitis Report [Letter]
por: Scadding, Glenis K, et al.
Publicado: (2023)

Using magnetic resonance imaging to quantify the inflammatory response following allergen challenge in allergic rhinitis
por: Leaker, Brian R., et al.
Publicado: (2015)

Is endoscopic sinus surgery sufficient to modify the evolution of adult AERD? Aspirin desensitization as a maintenance factor: systematic review
por: Conti, Diego M., et al.
Publicado: (2023)

MP29-02*’s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis
por: Scadding, Glenis, et al.
Publicado: (2015)

The need for patient-focused therapy for children and teenagers with allergic rhinitis: a case-based review of current European practice
por: Santos, Alexandra F, et al.
Publicado: (2015)

Short and long-term safety of MP29-02*: a new therapy for the treatment of allergic rhinitis
por: Price, David, et al.
Publicado: (2013)

Rhinitis and Sinusitis
por: Carroll, Michael P., et al.
Publicado: (2018)

A new therapy (MP29-02*) effectively targets the entire seasonal allergic rhinitis symptom complex
por: Price, David, et al.
Publicado: (2013)

Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis
por: Valero, Antonio, et al.
Publicado: (2020)

Assessment of disease control in allergic rhinitis
por: Demoly, Pascal, et al.
Publicado: (2013)

A new therapy (MP29-02*) effectively controls nasal symptoms of seasonal allergic rhinitis irrespective of severity
por: Scadding, Glenis, et al.
Publicado: (2013)

A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies
por: Hellings, Peter, et al.
Publicado: (2015)

Grand Challenges in Rhinology
por: Scadding, Glenis K.
Publicado: (2020)

A new therapy (MP29-02*) provides effective relief from all individual nasal and ocular symptoms of seasonal allergic rhinitis
por: Hellings, Peter, et al.
Publicado: (2013)

Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma
por: Price, David, et al.
Publicado: (2020)

A new efficacy parameter (complete/near complete symptom relief) in allergic rhinitis management: results with a new therapy MP29-02*
por: Bousquet, Jean, et al.
Publicado: (2013)

A new therapy (MP29-02*) effectively treats patients with seasonal allergic rhinitis who suffer most from the bothersome nasal symptom of congestion
por: Bachert, Claus, et al.
Publicado: (2013)

Allergens, germs and asthma
por: Scadding, Glenis Kathleen
Publicado: (2015)

P07 - Treatment load in the therapy management of allergic rhinitis: a UK retrospective database study
por: Carter, Victoria, et al.
Publicado: (2014)

UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study
por: Price, David B, et al.
Publicado: (2016)

The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey
por: Price, David, et al.
Publicado: (2015)

A New Grand Challenge in Rhinology: An Intranasal COVID Vaccine
por: Scadding, Glenis Kathleen
Publicado: (2022)

MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis
por: van Weissenbruch, Ranny, et al.
Publicado: (2020)

Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK
por: Scadding, Glenis, et al.
Publicado: (2017)

Allergic Rhinitis in Childhood and the New EUFOREA Algorithm
por: Scadding, Glenis Kathleen, et al.
Publicado: (2021)

Chronic Rhinosinusitis: Therapeutic Efficacy of Anti-Inflammatory and Antibiotic Approaches
por: Kariyawasam, Harsha H, et al.
Publicado: (2011)

The Quality of Health Information on Allergic Rhinitis, Rhinitis, and Sinusitis Available on the Internet
por: Chang, Mun Young, et al.
Publicado: (2015)

Editorial: Insights in rhinology: 2021/22
por: Smith, Peter Kenneth, et al.
Publicado: (2023)

Sinusitis, Rhinitis, Asthma, and the Single Airway Hypothesis
por: Chang, Christopher C.
Publicado: (2013)

Rhinitis, sinusitis and ocular disease – 2097. Dentomaxilofacial disorders in children with allergic rhinitis
por: Gallego, Claudia Ivonne, et al.
Publicado: (2013)

Laryngeal Inflammation in the Sudden Infant Death Syndrome
por: Scadding, Glenis K, et al.
Publicado: (2014)

A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
por: Hellings, Peter W., et al.
Publicado: (2015)

Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care
por: De Jong, Hilda J.I., et al.
Publicado: (2020)

Rhinitis, sinusitis and ocular disease – 2092. The MSNOT-20 questionnaire: repeatability and disease analysis of rhinitis/rhinosinusitis
por: Sami, Amtul Salam, et al.
Publicado: (2013)

Rhinitis, sinusitis and ocular disease – 2098. Exhaled NO may predict development of allergic rhinitis in children with asthma
por: Rha, Yeong Ho, et al.
Publicado: (2013)

A retrospective study on long-term efficacy of intranasal lysine-aspirin in controlling NSAID-exacerbated respiratory disease
por: Pendolino, Alfonso Luca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8bqd9p3jgp8qt90kiu99l4j1d7